Cumberland Pharmaceuticals Inc. Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset
Cumberland Pharmaceuticals Inc. (CPIX) reported Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset of $2.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset · last filed 2023-03-13
- Cumberland Pharmaceuticals Inc. consideration received for beneficial interest obtained for transferring financial asset for fiscal 2022 was $2.00M, a 0.00% change from fiscal 2021.
- Cumberland Pharmaceuticals Inc. consideration received for beneficial interest obtained for transferring financial asset for fiscal 2021 was $2.00M, a 60.00% decline from fiscal 2020.
- Cumberland Pharmaceuticals Inc. consideration received for beneficial interest obtained for transferring financial asset for fiscal 2020 was $5.00M, a 0.00% change from fiscal 2019.
- Cumberland Pharmaceuticals Inc. consideration received for beneficial interest obtained for transferring financial asset for fiscal 2019 was $5.00M.
| Period end | Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset 12 month | Consideration Received for Beneficial Interest Obtained for Transferring Financial Asset 12 month as first filed |
|---|---|---|
| 2022-12-31 | $2.00M 10-K · filed 2023-03-13 | |
| 2021-12-31 | $2.00M 10-K · filed 2022-03-11 | |
| 2020-12-31 | $5.00M 10-K · filed 2023-03-13 | $3.00M 10-K · filed 2021-03-12 |
| 2019-12-31 | $5.00M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |